Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2020-05-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for MedPacto, Inc. covering the period from January 1, 2020, to March 31, 2020. It contains detailed financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-13 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 98% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for MedPacto. It provides specific details such as the company name, stock code, reference price, and the effective date. This falls under the category of capital changes or share issues, specifically fitting the 'Share Issue/Capital Change' category.
2020-05-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. It details the share transactions (specifically a sale of shares) by an executive (Kang Dong Woo) of MedPacto. This type of filing is a standard regulatory disclosure for insider trading/director dealings.
2020-05-08 Korean
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a short announcement (under 1,000 characters) regarding the scheduling and logistics of an upcoming Investor Relations (IR) event. It provides the date, location, purpose, and instructions on where to access the presentation materials (KIND system). Since it is an announcement of an event and the availability of materials rather than the presentation itself, it falls under the Report Publication Announcement (RPA) category.
2020-05-04 Korean
기타경영사항(특허권취득)(자율공시)(암 예방 또는 치료용 약학적 조성물 및 이를 이용한 방법)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) by MedPacto regarding the acquisition of a patent for a pharmaceutical composition for cancer prevention or treatment. It details the patent name, content, and strategic utilization plan. Since it does not fit into specific financial reporting categories like 10-K or IR, and is a regulatory disclosure of a corporate event, it falls under the general regulatory filing category.
2020-04-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by a specific entity (Winvest Venture Partners) and its special related parties in the company MedPacto. This falls under the category of Major Shareholding Notification.
2020-04-29 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.